Literature DB >> 15958075

Expression of tumour necrosis factor receptor and Toll-like receptor 2 and 4 on peripheral blood leucocytes of human volunteers after endotoxin challenge: a comparison of flow cytometric light scatter and immunofluorescence gating.

X Wittebole1, S M Coyle, A Kumar, M Goshima, S F Lowry, S E Calvano.   

Abstract

Toll-like receptors (TLRs) are involved in the recognition of bacterial products and thus participate in the induction of the inflammatory cascade. However, much less is known about the evolution of leucocyte TLR expression during human inflammatory stress. We hypothesized that a decrease in leucocyte TLRs could account for the so-called tolerance or hyporesponsiveness state to subsequent stimulation with bacteria-derived products. Because of the profound monocytopenia that ensues after in vivo lipopolysaccharide (LPS) challenge, we also compared monocyte TLR expression using two different techniques of flow cytometric gating. In a first set of experiments, 17 healthy volunteers underwent LPS challenge. Blood was drawn at different time-points and analysed by flow cytometry using light scatter gating and one-colour analysis to assess the expression of the tumour necrosis factor receptor (TNFR) and TLR2 and TLR4 on both monocytes and granulocytes. In a second set of experiments, the assessment of those receptors was made using a more specific gating method that utilized light scatter and CD14 immunofluorescence in a two-colour analysis. This was performed using whole blood drawn from five healthy volunteers and incubated ex vivo for different time periods with or without LPS and in 12 volunteers who underwent LPS challenge in vivo. The pattern of expression for monocyte TNFR was similar for both types of gating. Using only the light scatter gating, an initial drop of TLR 2 and 4 was observed on monocytes. By contrast, when using light scatter x immunofluorescence gating, an up-regulation of these two receptors following both in vivo and in vitro LPS exposure was observed. LPS up-regulates the expression of TLRs on monocytes and granulocytes. Depending upon the methodology utilized, contrasting results were obtained with respect to TLR2 and TLR4 expression. The flow cytometric gating technique used is of importance in determining cellular TLR2 and TLR4 expression, especially in blood samples exhibiting significant monocytopenia.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15958075      PMCID: PMC1809417          DOI: 10.1111/j.1365-2249.2005.02831.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  30 in total

1.  Inhibition of lipopolysaccharide-induced signal transduction in endotoxin-tolerized mouse macrophages: dysregulation of cytokine, chemokine, and toll-like receptor 2 and 4 gene expression.

Authors:  A E Medvedev; K M Kopydlowski; S N Vogel
Journal:  J Immunol       Date:  2000-06-01       Impact factor: 5.422

2.  Toll-like receptor 4 surface expression on human monocytes and B cells is modulated by IL-2 and IL-4.

Authors:  Yoshinori Mita; Kunio Dobashi; Katsuaki Endou; Tadayoshi Kawata; Yasuo Shimizu; Tsugio Nakazawa; Masatomo Mori
Journal:  Immunol Lett       Date:  2002-04-01       Impact factor: 3.685

3.  Toll4 (TLR4) expression in cardiac myocytes in normal and failing myocardium.

Authors:  S Frantz; L Kobzik; Y D Kim; R Fukazawa; R Medzhitov; R T Lee; R A Kelly
Journal:  J Clin Invest       Date:  1999-08       Impact factor: 14.808

4.  Cutting edge: cell surface expression and lipopolysaccharide signaling via the toll-like receptor 4-MD-2 complex on mouse peritoneal macrophages.

Authors:  S Akashi; R Shimazu; H Ogata; Y Nagai; K Takeda; M Kimoto; K Miyake
Journal:  J Immunol       Date:  2000-04-01       Impact factor: 5.422

5.  Synergy and cross-tolerance between toll-like receptor (TLR) 2- and TLR4-mediated signaling pathways.

Authors:  S Sato; F Nomura; T Kawai; O Takeuchi; P F Mühlradt; K Takeda; S Akira
Journal:  J Immunol       Date:  2000-12-15       Impact factor: 5.422

6.  Hypoxia diminishes toll-like receptor 4 expression through reactive oxygen species generated by mitochondria in endothelial cells.

Authors:  Itaru Ishida; Hiroshi Kubo; Satoshi Suzuki; Tomoko Suzuki; Sachiko Akashi; Kunihiko Inoue; Sumiko Maeda; Hideaki Kikuchi; Hidetada Sasaki; Takashi Kondo
Journal:  J Immunol       Date:  2002-08-15       Impact factor: 5.422

7.  Peripheral blood leukocyte kinetics following in vivo lipopolysaccharide (LPS) administration to normal human subjects. Influence of elicited hormones and cytokines.

Authors:  R P Richardson; C D Rhyne; Y Fong; D G Hesse; K J Tracey; M A Marano; S F Lowry; A C Antonacci; S E Calvano
Journal:  Ann Surg       Date:  1989-08       Impact factor: 12.969

8.  TOLERANCE TO BACTERIAL PYROGENS : I. FACTORS INFLUENCING ITS DEVELOPMENT.

Authors:  P B Beeson
Journal:  J Exp Med       Date:  1947-06-30       Impact factor: 14.307

9.  Defective LPS signaling in C3H/HeJ and C57BL/10ScCr mice: mutations in Tlr4 gene.

Authors:  A Poltorak; X He; I Smirnova; M Y Liu; C Van Huffel; X Du; D Birdwell; E Alejos; M Silva; C Galanos; M Freudenberg; P Ricciardi-Castagnoli; B Layton; B Beutler
Journal:  Science       Date:  1998-12-11       Impact factor: 47.728

10.  Anti-inflammatory cytokines induce lipopolysaccharide tolerance in human monocytes without modifying toll-like receptor 4 membrane expression.

Authors:  C Moreno; J Merino; B Vázquez; N Ramírez; A Echeverría; F Pastor; A Sánchez-Ibarrola
Journal:  Scand J Immunol       Date:  2004-06       Impact factor: 3.487

View more
  10 in total

1.  Induction of endotoxin tolerance in vivo inhibits activation of IRAK4 and increases negative regulators IRAK-M, SHIP-1, and A20.

Authors:  Yanbao Xiong; Andrei E Medvedev
Journal:  J Leukoc Biol       Date:  2011-09-20       Impact factor: 4.962

2.  Lipid A-mediated tolerance and cancer therapy.

Authors:  Cheryl E Rockwell; David C Morrison; Nilofer Qureshi
Journal:  Adv Exp Med Biol       Date:  2010       Impact factor: 2.622

Review 3.  Toll-like receptor 4 modulation as a strategy to treat sepsis.

Authors:  X Wittebole; D Castanares-Zapatero; P F Laterre
Journal:  Mediators Inflamm       Date:  2010-04-14       Impact factor: 4.711

4.  Cellular metabolic regulators: novel indicators of low-grade inflammation in humans.

Authors:  Beatrice Haimovich; Zhiyong Zhang; Jacqueline E Calvano; Steve E Calvano; Ashwini Kumar; Marie A Macor; Siobhan Corbett; Susette M Coyle; Stephen F Lowry
Journal:  Ann Surg       Date:  2014-05       Impact factor: 12.969

5.  Influence of periodontal disease on systemic disease: inversion of a paradigm: a review.

Authors:  M Bansal; S Rastogi; N S Vineeth
Journal:  J Med Life       Date:  2013-06-25

6.  Formal modelling of toll like receptor 4 and JAK/STAT signalling pathways: insight into the roles of SOCS-1, interferon-β and proinflammatory cytokines in sepsis.

Authors:  Rehan Zafar Paracha; Jamil Ahmad; Amjad Ali; Riaz Hussain; Umar Niazi; Samar Hayat Khan Tareen; Babar Aslam
Journal:  PLoS One       Date:  2014-09-25       Impact factor: 3.240

7.  TLR4-induced IFN-gamma production increases TLR2 sensitivity and drives Gram-negative sepsis in mice.

Authors:  Stephan Spiller; Greg Elson; Ruth Ferstl; Stefan Dreher; Thomas Mueller; Marina Freudenberg; Bruno Daubeuf; Hermann Wagner; Carsten J Kirschning
Journal:  J Exp Med       Date:  2008-07-21       Impact factor: 14.307

Review 8.  Targeting toll-like receptors: promising therapeutic strategies for the management of sepsis-associated pathology and infectious diseases.

Authors:  Athina Savva; Thierry Roger
Journal:  Front Immunol       Date:  2013-11-18       Impact factor: 7.561

Review 9.  Inhibition of Toll-Like Receptor Signaling as a Promising Therapy for Inflammatory Diseases: A Journey from Molecular to Nano Therapeutics.

Authors:  Wei Gao; Ye Xiong; Qiang Li; Hong Yang
Journal:  Front Physiol       Date:  2017-07-19       Impact factor: 4.566

10.  Bidirectional effects of moxifloxacin on the pro‑inflammatory response in lipopolysaccharide‑stimulated mouse peritoneal macrophages.

Authors:  Zhenyu Qiu; Hongxia Yuan; Na Li; Xinjuan Yang; Xuemei Hu; Fengtai Su; Baiyi Chen
Journal:  Mol Med Rep       Date:  2018-10-22       Impact factor: 2.952

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.